A study to compare the effectiveness of suprascapular nerve block versus subacromial steroid injection in shoulder impingement syndrome.

A comparative study on efficacy of suprascapular nerve block versus subacromial steroid injection in shoulder impingement syndrome.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/08/009550

Enrollment

Registered

2017-08-30

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M754- Impingement syndrome of shoulder Health Condition 2: null- Patients suffering from shoulder impingement syndrome

Interventions

Intervention1: SUPRASCAPULAR NERVE BLOCK: Single sitting suprascapular nerve block at suprascapular notch located by landmark method with 40mg Depot methyl prednisolone,1ml 0.25% Bupivacaine and 2ml 2

Eligibility

Inclusion criteria

Inclusion criteria: (1) Clinically suggestive and USG and/or MRI confirming Neer Stage I & II impingement. (2) Not sufficiently responding to conservative treatment over 8weeks. (3) Aged 20 to 60 years. (4) Pain defined as a score of 5 points or more on a 10-cm visual analog scale (VAS) rated from 0 (no pain) to 10 (worst imaginable pain). (5) Patient mentally sound enough to communicate and participate in the study and can understand the parameters well.

Exclusion criteria

Exclusion criteria: 1. USG showing Rotator cuff tear. 2. Bleeding or clotting disorders. 3. Patients refusing intervention or participation. 4. The presence of another obvious associated cause for the pain (i.e., Primary osteoarthritis of glenohumeral joint, fracture, radiculopathy, myofascial pain, central neuropathic pain) 5. Severe motor weakness (muscle power of deltoid less than grade 2 on the manual muscle test). 6. Patients with Post myocardial infarction, Post stroke, Post mastectomy, prolonged immobilization. 7. The presence of an unstable medical condition or a known uncontrolled systemic disease, including cancer, diabetes, rheumatoid arthritis, endocrine disease, major depression, schizophrenia, & patients with persistent very high level of ESR & CRP. 8. Patients with contraindications of steroid injections i.e. overlying soft tissue sepsis, bacteraemia, anatomic inaccessibility, uncooperative patient, uncontrolled bleeding diathesis etc. 9. Patients who got intra-articular injection in shoulder within last six months.

Design outcomes

Primary

Measure	Time frame
Shoulder Pain And Disability Index (SPADI)Timepoint: At baseline, Postprocedure 2 weeks, 4 weeks & 12weeks.	—

Secondary

Measure	Time frame
Pain (VAS) score (0 to 10)Timepoint: At baseline, Postprocedure 2 weeks, 4 weeks & 12weeks.	—

Countries

India

Contacts

Public ContactAmbar Konar

IPGMER

rpramanik2000@yahoo.com09432594882

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026